References
- Tytgat G NJ, Nio C Y, Schotborgh R H. Reflux esophagitis. Scand J Gastroenterol 1990; 25: 1–12, Suppl 175
- Verlinden M. Review article: a role for gastrointestinal prokinetic agents in the treatment of reflux oesophagitis. Aliment Pharmacol Ther 1989; 3: 113–131
- McCallum R W, Prakash C, Campoli-Richards D M, Goa K L. Cisapride. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use as a prokinetic agent in gastrointestinal motility disorders. Drugs 1988; 36: 652–681
- Baldi F, Bianchi-Porro G, Dobrilla G, et al. Cisapride versus placebo in reflux esophagitis. A multicenter double-blind trial. J Clin Gastroenterol 1988; 10: 614–618
- Lepoutre L, Van Der Spek P, Vanderlinden I, Bollen J, Laukens P. Healing of grade-II and III oesophagitis through motility stimulation with cisapride. Digestion 1990; 45: 109–114
- Janisch H D. Cisaprid verus Ranitidin bei Refluxoesophagitis. Z Gastroenterol 1990; 28: 67–69, Suppl 1
- Galmiche J P, Fraitag B, Filoche B, et al. Double-blind comparison of cisapride and cimetidine in treatment of reflux esophagitis. Dig Dis Sci 1990; 35: 649–655
- Maleev A, Mendizova A, Popov P, et al. Cisapride and cimetidine in the treatment of erosive esophagitis. Hepatogastro-enterol 1990; 37: 403–407
- Dodds W, Champion M, Orr W, et al. Oral cisapride in GERD: a double-blind placebo-controlled multicenter trial [Abstract]. Gastroenterology 1989; 96(5)A126, part 2
- Blum A L, Verlinden M. The EUROCIS trialists. Cisapride prevents relapse of reflux oesophagitis [Abstract]. Gastroenterology 1990; 98(5)A22, part 2
- Toussaint J, Gossuin A, Deruyttere M, Hublé F, Devis G. Healing and prevention of relapse of reflux oesophagitis by cisapride. Gut 1991; 32: 1280–1285
- Pocock S J. Clinical trials—a practical approach. Wiley and Sons, Chichester 1983; 182–186
- Lee E T. Statistical methods for survival data analysis. Lifetime Learning Publications, Belmont, Calif.USA 1981
- Cox D R. Regression models and life tables. J R Stat Soc B 1972; 34: 187–220
- Hetzel D, Dent J, Reed W D, et al. Healing and relapse of severe peptic esophagitis after treatment with omeprazole. Gastroenterology 1988; 95: 903–912
- Sandmark S, Carlsson R, Fausa O, Lundell L. Omeprazole or ranitidine in the treatment of reflux esophagitis. Scand J Gastroenterol 1988; 23: 625–632
- Klinkenberg-Knol E C, Janssen J M, Lamers C P, et al. Cessation of long-term maintenance treatment with omeprazole in patients with resistant oesophagitis: effects on symptoms, endoscopy, serum gastrin levels and basal gastric acid output [Abstract]. Gastroenterology 1990; 98: A69
- Bardhan K D, Dely M J, Singh S, Morris P, Thompson M, Hinchliffe R FC. Refractory esophagitis: results of maintenance treatment with high-dose H2 receptor antagonists (H2RA) or omeprazole (OM) [Abstract]. Gastroenterology 1990; 98: A18
- Klinkenberg-Knol E C, Jansen J B, Lamers C B, Nelis F, Meuwissen S GM. Use of omeprazole in the management of reflux oesophagitis resistant to H2-receptor antagonists [Abstract]. Gastroenterology 1988; 94: A230
- Koop H, Wachtmann H, Eissele R, Arnold R. Efficacy and safety of long-term omeprazole maintenance therapy in H2-blocker-resistant reflux esophagitis healed by omeprazole [Abstract]. Gastroenterology 1990; 98: A70
- Koelz H R, Birchler R, Bretholz A, et al. Healing and relapse of reflux esophagitis during treatment with ranitidine. Gastroenterology 1986; 91: 1198–1205
- Armstrong D, Blum A L, The REZITIC study group. Full dose H2 receptor antagonist prophylaxis does not prevent relapse of reflux oesophagitis. Gut 1989; 30: A1494
- Ottenjann R, Siewert J R, Heilman K, Neiss A, Döpper H. Treatment of reflux-oesophagitis. Results of a multicenter trial with cimetidine. Proceedings of the International Esophageal Week, Munich, 1986, J R Siewert, A H Hölscher. Demeter Verlag, 190